Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.62, read 2026-11-03
Ethical does not pass the values gate
Price7.57 USD
Fair value10.00Our model only; only one analyst covers it, too few to cross-check it.
Ethical score70.0/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-11-01Read Markup10.19-25.8% to today Accumulation gives way to Markup after a 31% rise in 3 weeks
2026-10-11Read Accumulation7.79-2.9% to today Markdown gives way to Accumulation with volume flow in agreement
2026-10-02Read Markdown7.79-2.9% to today ✓Markup gives way to Markdown
2026-07-02Read Markup7.85-3.6% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
HighPeak Energy, Inc. holds its Markup at $7.57. The statistical read favours the buyers, held for 19 days.
As held on the ledger · 2026-11-04
Phase
Markup
Quantitative state
The statistical read favours the buyers, held for 19 days
Price at the screen
$7.57
Valuation
N/A trailing · -26.86 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.39
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
37.15%
Below 33%
Interest-bearing debt is 37.1% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
6.77%
Below 49%
Money owed to the company is 6.8% of assets, under the 49% limit.
Pass
Revenue purity
0.45%
Below 5%
Only 0.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
HighPeak Energy,'s business is in a permissible area, but its interest-bearing debt is about 37% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when HPK's ethical verdict changes
Today HPK does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our model only; only one analyst covers it, too few to cross-check it.
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly a 24% discount to our $10.00 fair value, 25.80% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 24.3% discount to the base estimate.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Where our models see it going: fair-value estimate $10.00, range not available, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Why it stands out
A 26%-growth business trading at just -26.9x forward earnings. That is a 24% discount to our $10.00 fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 1 analyst rate it Strong Buy with a $10.00 average target, about 32% above the screened price.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
HPK trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-05Markup$7.57-12.3%Entry 14
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 12.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 73% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-04Markup$8.63-0.5%Entry 13
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 73% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Markup$8.67-14.9%Entry 12
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 14.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 73% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markup$10.19+0.0%Entry 11
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 73% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $8. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markup · changed$10.19+0.8%Entry 10
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 73% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $8.
2026-10-25Accumulation$10.11+0.0%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 64% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $8.
2026-10-18Accumulation$10.11+29.8%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 29.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $8.
2026-10-11Accumulation · changed$7.79+0.0%Entry 7
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $8.
2026-10-02Markdown · changed$7.79+5.8%Entry 6
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 5.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $8.
2026-09-01Markup$7.37+0.0%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $8.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.